151 related articles for article (PubMed ID: 12823936)
1. Epstein-Barr virus and the B cell: a secret romance.
Schuster VH; Müschen M
Trends Microbiol; 2003 Jun; 11(6):243-5. PubMed ID: 12823936
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
Kurth J; Hansmann ML; Rajewsky K; Küppers R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
Au WY; Lam MF; Pang A; Leung RY; Kwong YL
Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471
[No Abstract] [Full Text] [Related]
7. Mouse model for acute Epstein-Barr virus infection.
Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
[TBL] [Abstract][Full Text] [Related]
8. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.
Mohamed G; Vrzalikova K; Cader FZ; Vockerodt M; Nagy E; Flodr P; Yap LF; Diepstra A; Kluin PM; Rosati S; Murray P
J Gen Virol; 2014 Sep; 95(Pt 9):1861-1869. PubMed ID: 24893782
[TBL] [Abstract][Full Text] [Related]
11. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
13. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas.
Bechtel D; Kurth J; Unkel C; Küppers R
Blood; 2005 Dec; 106(13):4345-50. PubMed ID: 16131568
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
17. B cells under influence: transformation of B cells by Epstein-Barr virus.
Küppers R
Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
[TBL] [Abstract][Full Text] [Related]
19. The intersection of Epstein-Barr virus with the germinal center.
Roughan JE; Thorley-Lawson DA
J Virol; 2009 Apr; 83(8):3968-76. PubMed ID: 19193789
[TBL] [Abstract][Full Text] [Related]
20. Atypical hyperplasia of the marginal zone of B follicles in a polymorphic Epstein-Barr virus-associated lymphoproliferative disorder occurring in an adolescent with human immunodeficiency virus infection.
Dargent JL; Haller A; Durdurez JP; Gennotte AF
Pediatr Dev Pathol; 2009; 12(1):59-62. PubMed ID: 18788890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]